$Scienture Holdings (SCNX.US)$
Scienture Holdings gains exclusive U.S. rights to commercialize REZENOPY®.
The agreement aligns with Scienture’s mission to advance public health initiatives.

$Cosmos Health (COSM.US)$
another 13G
lots of big buyers and insiders buying this stocks
hopefully it will rise very soon

$Cosmos Health (COSM.US)$
Potential Cosmos Health Inc.(NASDAQ:COSM) shareholders may wish to note that the Chairman & CEO, Grigorios Siokas, recently bought US$200k worth of stock, paying US$0.56 for each share. That's a very decent purchase to our minds and it grew their holding by a solid 10%.
Cosmos Health Insider Transactions Over The Last Year
In fact, the recent purchase by Grigorios Siokas was the biggest purchase of Cosmos Health shares made by an insider individual in the last twelve mon...

$Cosmos Health (COSM.US)$
Grigorios Siokas, the Chief Executive Officer of $COSM, bought 354,296 shares of the company on 02-24-2025 for an estimated $200,000. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 10.0%. Following this trade, they now own 3,897,016 shares of this class of $COSM stock.
$COSM Insider Trading Activity
$COSM insiders have traded $COSM stock on the open market 10 times ...

$Nixxy (NIXX.US)$
shorties are beating down so that they can buy at low price and then pump might happen

$Cosmos Health (COSM.US)$
Bullish Cosmos Health Insiders Loaded Up On US$539.0k Of Stock
editorial-team@simplywallst.com (Simply Wall St) Thu, February 20, 2025 at 9:18 PM GMT+113 min read
When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase stock, like in Cosmos Health Inc.'s(NASDAQ:COSM) instance, it's good news for shareholders.
While we would never suggest that investors should base their decisions solely on what the directors of a ...

$Cosmos Health (COSM.US)$
someone trying to lower the price or playing mind games by buying just one share. The future looks good for this. NFA

$AIM ImmunoTech (AIM.US)$
extracted from X, NFA
Our lead program is an immuno-modulator that has shown positive data published in
numerous well-respected journals and forums. Learn more: bit.ly/4gzyqnz

$SRM Entertainment (SRM.US)$
$Innate Pharma (IPHA.US)$ is doing well too

$Innate Pharma (IPHA.US)$
my swing for the day
it can be doubled
NFA